Literature DB >> 29637543

Dopamine-Related Genotypes and Physical Activity Change During an Intervention: The Lifestyle Interventions and Independence for Elders Study.

Andrea L Rosso1, Andrea L Metti1, Nancy W Glynn1, Robert M Boudreau1, W Jack Rejeski2, Nicolaas Bohnen3,4, Haiying Chen5, Neil M Johannsen6, Abby C King7, Todd M Manini8, Marco Pahor8, Stephanie A Studenski9, Carlos A Vaz Fragoso10, Caterina Rosano1.   

Abstract

OBJECTIVES: To determine whether intervention-induced physical activity (PA) changes in sedentary older adults differed according to dopamine-related genotype.
DESIGN: Randomized clinical trial (Lifestyle Interventions and Independence for Elders Trial (2010-13)).
SETTING: Multicenter study, 8 U.S. PARTICIPANTS: Volunteer sample of sedentary adults aged 70 to 89 at risk of disability (N=1635).
INTERVENTIONS: Structured PA versus health education (HE) for an average of 2.6 years. MEASUREMENTS: Single-nucleotide polymorphisms of dopamine-related genes (dopamine receptor (DR) D1, DRD2, DRD3, and catechol-O-methyltransferase (COMT)) were assessed. Average moderate to vigorous PA (MVPA) was calculated using accelerometry (min/d) at baseline and 6, 12, and 24 months. Between-arm MVPA differences according to genotype and genotype with square root-transformed MVPA separately according to arm were tested, stratified according to race, and adjusted for multiple comparisons.
RESULTS: White participants in the PA arm (n=513) had higher average square root transformed MVPA (4.91±1.91)than those in the HE arm (n=538) (4.51±1.82) (p=.001). Between-arm differences were greater for DRD2 Met/Met (high dopamine; HE: 4.76±1.80, PA: 5.53±1.60, p=.03) than Val/Val (low dopamine; HE: 4.58±1.92, PA: 4.81±1.83, p=.16); results were similar for COMT. In the PA arm, DRD2 Met/Met was associated with higher average MVPA (5.39±2.00) than Met/Val (4.46±2.51) (p=.01) and Val/Val (4.65±2.71) (p=.01). There were no associations for other genes. Associations were not significant in blacks but followed similar trends.
CONCLUSION: Higher dopamine signaling may support changes in PA during an intervention. The role of dopamine-related pathways in promoting PA participation and enhancing response to interventions in sedentary older adults should be studied. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01072500.
© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society.

Entities:  

Keywords:  aging; dopamine; physical activity; randomized controlled trial

Mesh:

Substances:

Year:  2018        PMID: 29637543      PMCID: PMC6105503          DOI: 10.1111/jgs.15369

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  40 in total

1.  D2 receptor genotype and striatal dopamine signaling predict motor cortical activity and behavior in humans.

Authors:  Leonardo Fazio; Giuseppe Blasi; Paolo Taurisano; Apostolos Papazacharias; Raffaella Romano; Barbara Gelao; Gianluca Ursini; Tiziana Quarto; Luciana Lo Bianco; Annabella Di Giorgio; Marina Mancini; Teresa Popolizio; Giuseppe Rubini; Alessandro Bertolino
Journal:  Neuroimage       Date:  2010-11-16       Impact factor: 6.556

Review 2.  Role of dopamine in the motivational and cognitive control of behavior.

Authors:  Roshan Cools
Journal:  Neuroscientist       Date:  2008-08       Impact factor: 7.519

3.  Physical activity in U.S.: adults compliance with the Physical Activity Guidelines for Americans.

Authors:  Jared M Tucker; Gregory J Welk; Nicholas K Beyler
Journal:  Am J Prev Med       Date:  2011-04       Impact factor: 5.043

4.  Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation.

Authors:  Jeff A Beeler; Rudolf P Faust; Susie Turkson; Honggang Ye; Xiaoxi Zhuang
Journal:  Biol Psychiatry       Date:  2015-07-26       Impact factor: 13.382

5.  Lifestyle interventions and independence for elders study: recruitment and baseline characteristics.

Authors:  Anthony P Marsh; Laura C Lovato; Nancy W Glynn; Kimberly Kennedy; Cynthia Castro; Kathryn Domanchuk; Erica McDavitt; Ruben Rodate; Michael Marsiske; Joanne McGloin; Erik J Groessl; Marco Pahor; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-28       Impact factor: 6.053

6.  A dopamine D2 receptor gene polymorphism and physical activity in two family studies.

Authors:  Riitta L Simonen; Tuomo Rankinen; Louis Pérusse; Arthur S Leon; James S Skinner; Jack H Wilmore; D C Rao; Claude Bouchard
Journal:  Physiol Behav       Date:  2003-04

7.  DRD2 C313T and DRD4 48-bp VNTR polymorphisms and physical activity of healthy men in Lower Silesia, Poland (HALS study).

Authors:  Pawel Jozkow; Malgorzata Slowinska-Lisowska; Lukasz Laczmanski; Marek Medras
Journal:  Ann Hum Biol       Date:  2012-12-07       Impact factor: 1.533

8.  Variation in dopamine genes influences responsivity of the human reward system.

Authors:  Jean-Claude Dreher; Philip Kohn; Bhaskar Kolachana; Daniel R Weinberger; Karen Faith Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

Review 9.  The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.

Authors:  Robert M Bilder; Jan Volavka; Herbert M Lachman; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

Review 10.  Genetic factors in exercise adoption, adherence and obesity.

Authors:  M P Herring; M H Sailors; M S Bray
Journal:  Obes Rev       Date:  2013-09-15       Impact factor: 9.213

View more
  8 in total

1.  Exercise activates vagal induction of dopamine and attenuates systemic inflammation.

Authors:  Guilherme Shimojo; Biju Joseph; Roshan Shah; Fernanda M Consolim-Colombo; Kátia De Angelis; Luis Ulloa
Journal:  Brain Behav Immun       Date:  2018-10-27       Impact factor: 7.217

2.  Catechol-O-Methyltransferase Genotype, Frailty, and Gait Speed in a Biracial Cohort of Older Adults.

Authors:  Shannon Mance; Andrea Rosso; Joshua Bis; Stephanie Studenski; Nico Bohnen; Caterina Rosano
Journal:  J Am Geriatr Soc       Date:  2020-10-12       Impact factor: 5.562

3.  Impact of dopamine-related genetic variants on physical activity in old age - a cohort study.

Authors:  Ing-Mari Dohrn; Goran Papenberg; Elisabeth Winkler; Anna-Karin Welmer
Journal:  Int J Behav Nutr Phys Act       Date:  2020-05-24       Impact factor: 6.457

Review 4.  Impact and Lessons From the Lifestyle Interventions and Independence for Elders (LIFE) Clinical Trials of Physical Activity to Prevent Mobility Disability.

Authors:  Marco Pahor; Jack M Guralnik; Stephen D Anton; Walter T Ambrosius; Steven N Blair; Timothy S Church; Mark A Espeland; Roger A Fielding; Thomas M Gill; Nancy W Glynn; Erik J Groessl; Abby C King; Stephen B Kritchevsky; Todd M Manini; Mary M McDermott; Michael E Miller; Anne B Newman; Jeff D Williamson
Journal:  J Am Geriatr Soc       Date:  2020-02-27       Impact factor: 5.562

5.  Long-term effects of adolescent sport experience, DRD2 and COMT genes, and their interaction on sport participation in adulthood.

Authors:  Chung Gun Lee; Hyoyoul Moon; Joon-Ho Kang; Joo Hee Choi; Ju Hyuk Kwon
Journal:  Brain Behav       Date:  2021-12-14       Impact factor: 2.708

Review 6.  Bidirectional Association between Physical Activity and Dopamine Across Adulthood-A Systematic Review.

Authors:  Adilson Marques; Priscila Marconcin; André O Werneck; Gerson Ferrari; Élvio R Gouveia; Matthias Kliegel; Miguel Peralta; Andreas Ihle
Journal:  Brain Sci       Date:  2021-06-23

Review 7.  Regulation of Voluntary Physical Activity Behavior: A Review of Evidence Involving Dopaminergic Pathways in the Brain.

Authors:  Anaissa Ruiz-Tejada; Janet Neisewander; Christos S Katsanos
Journal:  Brain Sci       Date:  2022-03-01

8.  The Role of Dopamine Receptor D2 in Bridging the Intention-Behavior Gap in Sport Participation.

Authors:  Seiyeong Park; Junhye Kwon; Chiyoung Ahn; Hae-Sung Cho; Hyo Youl Moon; Chung Gun Lee
Journal:  Int J Environ Res Public Health       Date:  2021-03-01       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.